ClinVar Miner

Submissions for variant NM_014846.4(WASHC5):c.647C>T (p.Pro216Leu)

gnomAD frequency: 0.00098  dbSNP: rs72720524
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000498521 SCV000589410 uncertain significance not provided 2017-06-21 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the KIAA0196 gene. The P216L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P216L variant is observed in 29/6612 (0.4%) alleles from individuals of European Finnish background and in 113/66722 (0.2%) alleles from individuals of European non-Finnish background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The P216L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Invitae RCV001086849 SCV000636814 likely benign Hereditary spastic paraplegia 8; Ritscher-Schinzel syndrome 2024-01-18 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001163828 SCV001325909 benign Hereditary spastic paraplegia 8 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Mayo Clinic Laboratories, Mayo Clinic RCV000498521 SCV001714893 uncertain significance not provided 2023-05-02 criteria provided, single submitter clinical testing PP3
Athena Diagnostics Inc RCV001662485 SCV001880460 benign not specified 2020-11-25 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000498521 SCV004010798 uncertain significance not provided 2023-07-01 criteria provided, single submitter clinical testing WASHC5: PP3

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.